Showing results (301-310 of 567) with videos related to
Sort By:
Pageof 57
Archiv Fur Psychiatrie Und Nervenkrankheiten|December 28, 1977
[Adult metachromatic leukodystrophy manifested as schizophrenic psychosis (author's transl)]P Kothbauer, K Jellinger, H Gross, et al.Journal of Neuropathology and Experimental Neurology|May 22, 1998
Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosisC Stadelmann, W Brück, C Bancher, et al.Neuropathology and Applied Neurobiology|October 16, 2010
Review: sporadic cerebral amyloid angiopathyJ Attems, K Jellinger, D R Thal, et al.FEBS Letters|April 24, 1990
A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick diseaseR Weiler, H Lassmann, P Fischer, et al.Neurology|March 1, 1994
Syndrome of continuous muscle fiber activity and plasmacytoma with IgM paraproteinemiaU Zifko, M Drlicek, E Machacek, et al.Journal of Neural Transmission. Supplementum|November 29, 2002
A broader horizon of Alzheimer pathogenesis: ALZAS--an early serum biomarker?E Kienzl, K Jellinger, B Janetzky, et al.Journal of Neural Transmission. Supplementum|January 1, 1983
General properties of 14C-L-Valine-binding to human brain tissueP Riederer, E Kienzl, K Jellinger, et al.Acta Neurochirurgica|January 1, 1979
Combination chemotherapy (COMP protocol) and radiotherapy of anaplastic supratentorial gliomasK Jellinger, P Kothbauer, D Volc, et al.Cognitive Neuropsychiatry|November 25, 2014
A PET Study of Persistent Psychogenic Amnesia Covering the Whole Life SpanH J Markowitsch, G R Fink, A Thone, et al.The Keio Journal of Medicine|June 1, 1989
Positron emission tomography findings in dementia disorders: contributions to differential diagnosis and objectivizing of therapeutic effectsW D Heiss, K Herholz, G Pawlik, et al.Pageof 57